Methionine metabolism and liver disease

Annual Review of Nutrition

Volumn 28, Issue , 2008, Pages 273-293

  Mato, José M ^a   Martínez Chantar, M Luz ^a   Lu, Shelly C ^b  

^a CIC BIOGUNE   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Fatty liver disease; Folate cycle; Hepatocellular carcinoma; S adenosylhomocysteine; S adenosylmethionine; Transsulfuration pathway

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSYLHOMOCYSTEINASE; ADENYLATE KINASE; BETAINE; CHOLINE; CYSTATHIONINE BETA SYNTHASE; DNA; FOLIC ACID; GLUTATHIONE; GLYCINE METHYLTRANSFERASE; GUANIDINOACETATE METHYLTRANSFERASE; METHIONINE; METHIONINE DERIVATIVE; METHIONINE SYNTHASE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARBOHYDRATE METABOLISM; CARBON METABOLISM; CELL PROLIFERATION; DNA SYNTHESIS; DOG; ENERGY BALANCE; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME METABOLISM; FATTY LIVER; GENE; GENE DISRUPTION; GENE MUTATION; GENETIC POLYMORPHISM; GNMT GENE; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN TREATMENT; LIPID METABOLISM; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; LIVER PROTECTION; MAT1A GENE; METHIONINE METABOLISM; METHYLATION; MOUSE; NONHUMAN; NUTRIENT LOADING; OXIDATIVE STRESS; PANCREAS RESECTION; PEMT GENE; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; REVIEW; STEATOSIS; SULFURATION;

ANIMALS; CHOLINE; CHOLINE DEFICIENCY; FOLIC ACID DEFICIENCY; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; METHIONINE; METHIONINE ADENOSYLTRANSFERASE; METHYLATION;

ANIMALIA; CANIS FAMILIARIS; MUS; RATTUS;

EID: 50949132080     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.28.061807.155438     Document Type: Review

References (121)

1. Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD. 2001. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis; results of a pilot study. Am. J. Gastroenterol. 96:2711-17
2. Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Anto M, et al. 2005. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology 41:995-1003
3. Ansorena G, García-Trevijano ER, Martínez-Chantar ML, Huang ZZ, Chen LX, et al. 2002. S-Adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology 35:274-80
4. Augoustides-Savvopoulou P, Luka ZS, Karyda S, Stabler SP, Allen RH, et al. 2003. Glycine N-methyltransferase deficiency: a new patient with a novel mutation. J. Inherit. Metab. Dis. 26:745-49
5. Avila MA, Berasain C, Torres L, Martín-Duce A, Corrales FJ, et al. 2000. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33:907-14
6. Banerjee RV, Matthews RG. 1990. Cobalamin-dependent methionine synthase. FASEB J. 4:1450-59
7. Baric I, Cuk M, Fumic K, Vugrek O, Allen RH, et al. 2005. S-Adenosylhomocysteine hydrolase deficiency: A second patient, the younger brother of the index patient, and outcomes during therapy. J. Inherit. Metab. Dis. 28:885-902
8. Baric I, Fumic K, Glenn B, Cuk M, Schulze A, et al. 2004. S-Adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc. Natl. Acad. Sci. USA 101 4234-39
9. Boison D, Scheurer L, Zumsteg V, Rulicke T, Litynski P, et al. 2002. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc. Natl. Acad. Sci. USA 99:5985-90
10. Buist NRM, Glenn B, Vugrek O, Wagner C, Stabler S, et al. 2006. S-Adenosylhomocysteine hydrolase deficiency in a 26-year-old man. J. Inherit. Metab. Dis. 29:538-45
11. Cabrero C, Puerta J, Alemany S. 1987. Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. Eur. J. Biochem. 170:299-304
12. Cai J, Mao Z, Hwang JJ, Lu SC. 1998. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res. 58:1444-50
13. Cantoni GL. 1975. Biochemical methylations: selected aspects. Annu. Rev. Biochem. 45:285-306
14. Carmel R, Green R, Rosenblatt DS, Watkins D. 2003. Update on cobalamin, folate, and homocysteine. Hematol. Am. Soc. Hematol. Educ. Program 2003:62-81
15. Chamberlin ME, Ubagai T, Mudd SH, Wilson WG, Leonard JV, et al. 1996. Demyelination of the brain is associated with human methionine adenosyltransferase I/III deficiency. J. Clin. Invest. 98:1021-27
16. Chen L, Zeng Y, Yang H, Lee TD, French SW, et al. 2004. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J. 18:914-16
17. Chen YM, Shin JY, Tzeng SJ, Shih LS, Chwn YJ, et al. 1998. Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int. J. Cancer 75:787-93
18. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, et al. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10:433-43
19. Clarke S, Banfield K. 2001. S-Adenosylmethionine-dependent methyltransferases. In Homocysteine in Health and Disease, ed. R Carmel, DW Jacobsen, pp. 63-78. New York/London: Cambridge Univ. Press
20. Clarke SG. 2006. Inhibition of mammalian protein methyltransferases by 5′-methylidiioadenosine (MTA): a mechanism of action of dietary SAMe? In The Enzymes, ed. SG Clarke, F Tamanoi, 24:467-93. New York: Elsevier/Acad. Press. 3rd ed.
21. Collinsova M, Strakova J, Jiracek J, Garrow TA. 2006. Inhibition of betaine-homocysteine S-methyltransferase causes hyperhomocysteinemia in mice. J. Nutr. 136:1493-97
22. Craig SAS. 2004. Betaine in human nutrition. Am. J. Clin. Nutr. 80:539-49
23. Cravo ML, Gloria LM, Selhub J, Nadeu MR, Camilo ME, et al. 1996. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am. J. Clin. Nutr. 63:220-24
24. Cui Z, Houweling M, Vance DE. 1994. Suppression of rat hepatoma cell growth by expression of phosphatidylethanolamine N-methyltransferase. J. Biol. Chem. 269:24531-33
25. DeLong CJ, Shen YJ, Thomas MJ, Cui Z. 1999. Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J. Biol. Chem. 274:29683-88
26. Duce AM, Ortiz P, Cabrero C, Mato JM. 1988. S-Adenosyl-L- methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 8:1530-34
27. Elmore CL, Wu X, Leclerc D, Watosn ED, Bottiglieri T, et al. 2007. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol. Genet. Metab. 91:85-97
28. Esteller M. 2007. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8:286-98
29. Finkelstein JD. 1990. Methionine metabolism in mammals. J. Nutr. Biochem. 1:228-37
30. Finkelstein JD, Kyle WE, Martin JJ, Pick AM. 1975. Activation of cystathionine synthase by S-adenosylmethionine and S-adenosylethionine. Biochem. Biophys. Res. Commun. 66:81-87
31. Finkelstein JD, Martin JJ. 1984. Methionine metabolism in mammals: distribution of homocysteine between competitive pathways. J. Biol. Chem. 259:9508-13
32. Finkelstein JD, Mudd SH, Irrevere F, Laster L. 1964. Homocystinuria due to cystathionine synthase deficiency: the mode of inheritance. Science 146:785-87
33. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:111-13
34. García-Trevijano ER, Latasa MU, Carretero MV, Berasain C, Mato JM, et al. 2000. S-Adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differential status of the liver. FASEB J. 14:2511-18
35. García-Trevijano ER, Martínez-Chantar ML, Latasa MU, Mato JM, Avila MA. 2002. NO sensitizes rat hepatocytes to proliferation by modifying S-adenosylmethionine levels. Gastroenterology 12:1355-63
36. Ghandour H, Chen Z, Selhub J, Rozen R. 2004. Mice deficient in methylenetetrahydrofolate reductase exhibit tissue-specific distribution of folates. J. Nutr. 134:2975-78
37. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, et al. 1999. The structure and properties of methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat. Genet. 7:195-200
38. Halsted CH, Villanueva JA, Devlin AM, Niemela O, Parkkila S, et al. 2002. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc. Natl. Acad. Sci. USA 99:10072-77
39. Hardie DG, Hawley SA. 2001. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112-19
40. Hevia H, Varela-Rey M, Corrales FJ, Berasain C, Martínez-Chantar ML, et al. 2004. 5′-Methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology 39:1088-98
41. Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, et al. 1981. Evidence of impairment of transsulfuration pathway in cirrhosis. Gastroenterology 81:668-75
42. Houweling M, Cui Z, Tessitore L, Vance DE. 1997. Induction of hepatocyte proliferation after partial hepatectomy is accompanied by a markedly reduced expression of phosphatidylethanolamine N- methyltransferase-2. Biochim. Biophys. Acta 1346:1-9
43. Houweling M, Cui Z, Vance DE. 1995. Expression of phosphatidylethanolamine N-methyltransferase-2 cannot compensate for an impaired CDP-choline pathway in mutant Chinese hamster ovary cells. J. Biol. Chem. 270:16277-82
44. Ignoul S, Eggermont J. 2005. CBS domains: structure, function, and pathology in human proteins. Am. J. Physiol. Cell Physiol. 289:1369-78
45. Jakubowski H. 1999. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 13:2277-83
46. Jenks DA, Mathews RG. 1987. Allosteric inhibition of methylenetetrahydrofolate reductase by S-adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J. Biol. Chem. 262:2485-93
47. Ji C, Kaplowitz N. 2003. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124:1488-99
48. Ji C, Kaplowitz N. 2004. Hyperhomocysteinemia, endoplasmic reticulum stress and alcoholic liver injury. World J. Gastroenterol. 10:1699-708
49. Katz JE, Dlakic M, Clarke S. 2003. Automated identification of putative methyltransferases from genomic open reading frames. Mol. Cell. Proteomics 2:525-40
50. Kim SZ, Santamaría E, Jeong TE, Levy HL, Mato JM, et al. 2002. Methionine adenosyltransferase I/III deficiency: two Korean compound heterozygous siblings with a novel mutation. J. Inherit. Metab. Dis 25:661-71
51. Kotb M, Mudd SH, Mato JM, Geller AM, Kredich NM, et al. 1997. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet. 13:51-52
52. Kraus JP, Janosik M, Kozich V, Mandell R, Shih V, et al. 1999. Cystathionine beta-synthase mutations in homocystinuria. Hum. Mutat. 13:362-75
53. Kutzbach C, Stokstad ELR. 1967. Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine. Biochim. Biophys. Acta 139:217-20
54. Kutzbach C, Stokstad ELR. 1971. Mammalian methylene-tetrahydrofolate reductase: partial purification, properties and inhibition by S-adenosylmethionine. Biochim. Biophys. Acta 250:459-77
55. Laster L, Mudd SH, Finkelstein JD, Irreverre F. 1965. Homocystinuria due to cystathionine synthase deficiency: the metabolism of L-methionine. J. Clin. Invest. 44:1708-19
56. Lee SJ, Lee DH, Yoo HW, Koo SK, Park ES, et al. 2005. Identification and functional analysis of cystathionine beta-synthase gene mutations in patients with homocystinuria. J. Hum. Genet. 50:648-54
57. Leulliot N, Quevillon-Chereul S, Sorel I, de la Sierra-Galay IL, Collinet B, et al. 2004. Structure of protein phosphatase methyltransferase 1 (PPM1), a leucine carboxyl methyltransferase involved in the regulation of protein phosphatase 2A activity. J. Biol. Chem. 279:8351-58
58. -/- mice develop chronic hepatitis and glycogen storage disease in the liver. Hepatology 46:1413-25
59. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, et al. 2006. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3:321-31
60. Loenen WA. 2006. S-Adenosylmethionine: jack-of-all-trades and master of everything? Biochem. Soc. Trans. 34:330-33
61. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, et al. 2001. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc. Natl. Acad. Sci. USA 98:5560-65
62. Luka Z, Capdevila A, Mato JM, Wagner C. 2006. A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res. 15:393-97
63. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter D, et al. 1997. Methylenetetrahydrofolate reductase polymorphism, reduced risk of colorectal cancer and dietary interactions. Cancer Res. 57:1098-102
64. Martínez-Chantar ML, Corrales FJ, Martínez-Cruz A, García-Trevijano ER, Huang ZZ, et al. 2002. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16:1292-94
65. 63a. Martínez-Chantar ML, Vázquez-Chantada M, Ariz U, Martínez N, Varela M, et al. 2008. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology. Dec. 19. Epub ahead of print
66. Martínez-Chantar ML, Vázquez-Chantada M, Garnacho M, Latasa MU, Varela-Rey M, et al. 2006. S-Adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology 131:223-32
67. Mato JM, Cámara J, Fernández de Paz J, Caballería L, Coll S, et al. 1999. S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized placebo-controlled, double-blind, multicenter trial. J. Hepatol. 30:1081-89
68. Mato JM, Corrales FJ, Lu SC, Avila MA. 2002. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J. 16:15-26
69. Mato JM, Lu SC. 2007. Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 45:1306-12
70. Migchielsen AA, Breuer ML, van Roon MA, te Riele H, Zurcher C, et al. 1995. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestine cell death. Nat. Genet. 10:279-87
71. x) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. EMBO J. 13:1806-16
72. Mudd SH, Brosnan JT, Brosnan ME, Jacobs RL, Stabler SP, et al. 2007. Methyl balance and transmethylation fluxes in humans. Am. J. Clin. Nutr. 85:19-25
73. Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti GU, et al. 2001. Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia. J. Inherit. Metab. Dis. 24:448-64
74. Mudd SH, Finkelstein JD, Irreverre F, Laster L. 1964. Homocystinuria: an enzymatic defect. Science 143:1443-45
75. Namekata K, Enokido Y, Ishii I, Nagai Y, Harada T, et al. 2004. Abnormal lipid metabolism in cystathionine β-synthase-deficient mice, an animal model for hyperhomocysteinemia. J. Biol. Chem. 279:52961-69
76. Nieto N, Cederbaum AL. 2005. S-Adenosylmethionine blocks collagen I production by preventing transforming growth factor-β induction of the COL1A2 promoter. J. Biol. Chem. 280:30963-74
77. Noga AA, Stead LM, Zhao Y, Brosnan ME, Brosnan JT, et al. 2003. Plasma homocysteine is regulated by phospholipids methylation. J. Biol. Chem. 278:5952-55
78. Ogawa H, Fujioka M. 1982. Purification and properties of glycine N-methyltransferase from rat liver. J. Biol. Chem. 257:3447-52
79. Olteanu H, Banerjee R. 2001. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J. Biol. Chem. 276:35558-63
80. Ou X, Yang H, Ramani K, Ara AI, Chen H, et al. 2007. Inhibition of human betaine homocysteine methyltransferase expression by S-adenosylmethionine. Biochem. J. 401:87-96
81. Pajares MA, Durán C, Corrales FJ, Pliego MM, Mato JM. 1992. Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. J. Biol. Chem. 267:17598-605
82. Park EI, Garrow TA. 1999. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J. Biol. Chem. 274:7816-24
83. Pascale RM, Simile MM, De Miglio MR, Feo F. 2002. Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine. Alcohol 27:193-98
84. Pérez-Mato I, Sánchez del Pino MM, Chamberlin ME, Mudd SH, Mato JM, et al. 2001. Biochemical basis for the dominant inheritance of hypermethioninemia associated with the R264H mutation of the MAT1A gene. J. Biol. Chem. 276:12803-9
85. Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, et al. 1999. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 23:228-32
86. Poirier LA. 2002. The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. J. Nutr. 132:2336-39S
87. Prudova A, Bauman Z, Braun A, Vivitsky V, Lu SC, et al. 2006. S-Adenosylmethionine stabilizes cystathionine β-synthase and modulates redox capacity. Proc. Natl. Acad. Sci. USA 103:6489-94
88. Purohit V, Abdelmalek MF, Barve S, Benevenga NJ, Halsted CH, et al. 2007. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am. J. Clin. Nutr. 86:14-24
89. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, et al. 1994. Pathology of atheromatous lesions in inbred and genetically engineered mice. Arterioscler. Thromb. Vasc. Biol. 14:1480-97
90. Reo NV, Adinehzadeh M, Foy BD. 2002. Kinetic analysis of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis using (13)C NMR spectroscopy. Biochim. Biophys. Acta 1580:171-88
91. Robert K, Chassé J-F, Santiard-Baron D, Vayssettes C, Chabli A, et al. 2003. Altered gene expression in liver from a murine model of hyperhomocysteinemia. J. Biol. Chem. 278:31504-11
92. Robert K, Nehmé J, Bourdon E, Pivert G, Friquet B, et al. 2005. Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 128:1405-15
93. Rosenblatt DS. 1995. Inherited disorders of folate transport and metabolism. In Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 3111-28. New York: McGraw-Hill. 7th ed.
94. Saffroy R, Pham P, Gross-Goupil, Castera L, Azoulay D, et al. 2004. The MTHFR 677C>T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis 25:1443-48
95. Sánchez del Pino MM, Corrales FJ, Mato JM. 2000. Hysteretic behavior of methionine adenosyltransferase III. J. Biol. Chem. 275:23476-82
96. Schmidt A, Marescau B, Boehm EA, Renema WK, Peco R, et al. 2004. Severely altered guanidine compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum. Mol. Genet. 13:905-21
97. Sáchwahn BC, Chen Z, Laryea MD, Wendel U, Lussier-Cacan S, et al. 2003. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J. 17:512-14. DOI: 10.1096/fj.02-0456fje
98. Sierra EE, Goldman ID. 1999. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin. Oncol. 26:11-23
99. Song J, da Costa KA, Fischer LM, Kohlmeier M, Kwock L, et al. 2005. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J. 19:1266-71
100. Spiegelstein O, Eudy JD, Finnell RH. 2000. Identification of two putative novel folate receptor genes in humans and mouse. Gene 258:117-25
101. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. 2006. Is it time to reevaluate methyl balance in humans? Am. J. Clin. Nutr. 83:5-10
102. Stipanuk MH. 2004. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu. Rev. Nutr. 24:539-77
103. Stöckler S, Hanefeld F, Frahm J. 1996. Creatine replacement therapy in guanidinoacetat: methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348:789-90
104. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403:41-45
105. Sullivan DM, Hoffman JL. 1983. Fractionation and kinetic properties of rat liver and kidney methionine adenosyltransferase isoenzymes. Biochemistry 22:1636-41
106. Swanson DA, Liu M-L, Baker L, Garrett L, Stitzel M, et al. 2 001. Targeted disruption of the methionine synthase gene in mice. Mol. Cell. Biol. 21:1058-65
107. Tseng T-L, Shib Y-P, Huang Y-C, Wang C-K, Chen P-H, et al. 2003. Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer. Cancer Res. 63:647-54
108. Ubagai T, Lei KJ, Huang S, Mudd SH, Levy HL, et al. 1995. Molecular mechanisms of an inborn error of methionine pathway. Methionine adenosyltransferase deficiency. J. Clin. Invest. 96:1943-47
109. Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, et al. 1997. Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272:17012-17
110. Veal N, Hsieh CL, Xiong S, Lu SC, Tsukamoto H. 2004. Inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha promoter activity by S-adenosylmethionine and 5′-methylthioadenosine. Am. J. Physiol. 287:G352-62
111. Virshup DM. 2000. Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell Biol. 12:180-85
112. Wakamiya M, Blackburn MR, Jurecic R, McArthur MJ, Geske RS, et al. 1995. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc. Natl. Acad. Sci. USA 92:3673-77
113. Walkey CJ, Donohue LR, Bronson R, Agellon LB, Vance DE. 1997. Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase. Proc. Natl. Acad. Sci. USA 94:12880-85
114. Walkey CJ, Yu L, Agellon LB, Vance DE. 1998. Biochemical and evolutionary significance of phospholipids methylation. J. Biol. Chem. 273:27043-46
115. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, et al. 1995. Mice deficient in cystathionine beta-synthase: animal model for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 92:1585-89
116. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64:169-72
117. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sond SK, et al. 2001. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107:1263-73
118. Yamada K, Gravel RA, Toraya T, Matthews RG. 2006. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc. Natl. Acad. Sci. USA 103:9476-81
119. Yang H, Sadda MR, Li M, Zeng Y, Chen L, et al. 2004. S-Adenosylmethionine and its metabolite methylthioadenosine induce apoptosis in HepG2 cells: role of protein phosphatase 1 and Bcl-x(S). Hepatology 40:221-31
120. Yuan JM, Lu SC, van den Berg D, Govindarajan S, Zhang ZQ, et al. 2007. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidilate synthase genes and risk of hepatocellular carcinoma. Hepatology 467:749-58
121. Zhu X, Song J, Mar MH, Edwards LJ, Zeisel SH. 2003. Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochem. J. 370:987-93